Clinical Trials Browser

Phase 2 × Metastatic Malignant Female Reproductive System Neoplasm × Clear all

NCT04516135 2026-02-25

Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers

Phase 2 Active not recruiting

Metastatic Malignant Female Reproductive System Neoplasm

NCT04395079 2026-02-09

Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

Phase 2 Active not recruiting

Metastatic Malignant Female Reproductive System Neoplasm